Our shareholders ownership updated per June 14, 2019
Shareholder
Number of shares
%
1. Gjelsten Holding AS
5.685.450
20,41%
2. Canica AS
2.197.150
7,89%
3. Inven2 AS
2.021.775
7,26%
4. Watrium AS
1.620.925
5,82%
5. Radiumhospitalets Forskningsstiftelse
1.395.875
5,01%
6. Langøya Invest AS
1.226.325
4,40%
7. Immuneed AB
866.400
3,11%
8. Helene Sundt AS
764.375
2,74%
9. CGS Holding AS
764.375
2,74%
10. SEB Prime Solutions Sissener Canopus
662.843
2,38%
11. Sundt AS
617.150
2,22%
12. KLP AksjeNorge
600.000
2,15%
13. Danske Invest Norge Vekst
600.000
2,15%
14. Brown Brothers Harriman (Lux.) SCA (Nominee)
518.930
1,86%
15. Prieta AS
485.175
1,74%
16. Verdipapirfondet Nordea Avkastning
449.100
1,61%
17. JPMorgan Chase Bank, N.A., London (Nominee)
429.417
1,54%
18. Kommunal Landspensjonskasse
400.000
1,44%
19. ABN AMRO Global Custody Services (Nominee)
315.248
1,13%
20. Verdipapirfondet Nordea Kapital
269.460
0,97%
20 largest shareholders
21.889.973
78,57%
Other shareholders
5.970.427
21,43%
Total
27.860.400
100,00%
